top of page

Erika Loredo

Postdoctoral fellow

Dr. Loredo obtained her M.Sc. degree in Pharmacy in 2017 from the Autonomous University of Nuevo León (UANL), México, and then obtained a Ph.D. in medicinal chemistry from the same University in 2020. 

Dr. Loredo joined our group in January 2023, and she is currently involved in the chemical synthesis of novel proteolysis targeting chimeras with binding affinity for the DBD-FOXM1.

Antonio Vega: Team Members
bottom of page